Literature DB >> 16766546

Phosphate binders and management of hyperphosphataemia in end-stage renal disease.

Vincenzo Savica1, Lorenzo A Calò, Pietro Monardo, Domenico Santoro, Guido Bellinghieri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16766546     DOI： 10.1093/ndt/gfl289

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  7 in total

1.  Treatment options of secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease stages 3 and 4: an historic review.

Authors:  Piergiorgio Bolasco
Journal:  Clin Cases Miner Bone Metab       Date:  2009-09

2.  Salivary phosphate-binding chewing gum reduces hyperphosphatemia in dialysis patients.

Authors:  Vincenzo Savica; Lorenzo A Calò; Paolo Monardo; Paul A Davis; Antonio Granata; Domenico Santoro; Rodolfo Savica; Rosa Musolino; Maria Cristina Comelli; Guido Bellinghieri
Journal:  J Am Soc Nephrol       Date:  2008-11-19       Impact factor: 10.121

Review 3.  Phosphate binders for the treatment of chronic kidney disease: role of iron oxyhydroxide.

Authors:  Valeria Cernaro; Domenico Santoro; Antonio Lacquaniti; Giuseppe Costantino; Luca Visconti; Antoine Buemi; Michele Buemi
Journal:  Int J Nephrol Renovasc Dis       Date:  2016-02-02

4.  Synthesis of Mg-Fe-Cl hydrotalcite-like nanoplatelets as an oral phosphate binder: evaluations of phosphorus intercalation activity and cellular cytotoxicity.

Authors:  Yung-Feng Lung; Ying-Sui Sun; Chun-Kai Lin; Jun-Yen Uan; Her-Hsiung Huang
Journal:  Sci Rep       Date:  2016-09-01       Impact factor: 4.379

Review 5.  Lanthanum Carbonate Opacities-A Systematic Review.

Authors:  Jan Kampmann; Nina Pirschel Hansen; Anders Nikolai Ørsted Schultz; Andreas Hjelm Brandt; Frans Brandt
Journal:  Diagnostics (Basel)       Date:  2022-02-11

6.  Prescribing pattern of medicines in chronic kidney disease with emphasis on phosphate binders.

Authors:  Chaitali S Bajait; Sonali A Pimpalkhute; Smita D Sontakke; Kavita M Jaiswal; Amruta V Dawri
Journal:  Indian J Pharmacol       Date:  2014 Jan-Feb       Impact factor: 1.200

7.  Reduction of costs for anemia-management drugs associated with the use of ferric citrate.

Authors:  Anila Thomas; Leif E Peterson
Journal:  Int J Nephrol Renovasc Dis       Date:  2014-05-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.